Virtus ETF Advisers’s Idexx Laboratories IDXX Stock Holding History

Virtus ETF Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.6K	Hold	41	–	–	0.01%	455
2026 Q1	$23K	Hold	41	–	–	0.01%	436
2025 Q4	$27.7K	Sell	41 -200	-83%	-$136K	0.01%	423
2025 Q3	$154K	Buy	+241	New	+$146K	0.08%	246
2024 Q2	–	Sell	-1,429	Closed	-$772K	–	464
2024 Q1	$772K	Buy	1,429 +62	+5%	+$33.9K	0.41%	104
2023 Q4	$759K	Buy	1,367 +20	+1%	+$9.39K	0.48%	20
2023 Q3	$589K	Sell	1,347 -226	-14%	-$113K	0.36%	150
2023 Q2	$790K	Buy	+1,573	New	+$754K	0.47%	67
2022 Q3	–	Sell	-1,525	Closed	-$535K	–	455
2022 Q2	$535K	Buy	+1,525	New	+$622K	0.2%	221
2018 Q4	–	Sell	-69	Closed	-$17K	–	348
2018 Q3	$17K	Buy	+69	New	+$16.7K	﹤0.01%	290

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Virtus ETF Advisers's IDXX Position: Q2 2026 in Review

Virtus ETF Advisers held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 41 shares worth $21.6K. The position accounts for 0.01% of the portfolio, ranked #455.

Virtus ETF Advisers first reported a position in IDXX in Q3 2018 and has held it in 10 quarters since. The position peaked at $790K in Q2 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Virtus ETF Advisers held 41 shares of Idexx Laboratories worth $21.6K as of Q2 2026.
Virtus ETF Advisers left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.01% of Virtus ETF Advisers's portfolio in Q2 2026, its #455 holding.
Virtus ETF Advisers first reported a position in Idexx Laboratories in Q3 2018 and has held it in 10 quarters since.
Virtus ETF Advisers's Idexx Laboratories position peaked at $790K in Q2 2023.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.